Short abstract

This panel will examine Canada’s progress and challenges in implementing open science while linking to the global context. It will gather insights from research institutes, metascientists, funders and intellectual property experts, to discuss strategies for advancing and measuring open science.

Long abstract

When you think of Canada, images of hockey rinks, snowy landscapes, Tim Hortons coffee, and breathtaking wilderness might come to mind. In this panel, we are diving into a different side of Canada: its contributions to open science. We will bring together key players from across the research ecosystem—research institutions, national funders, metascientists, and academia-industry partnerships—to discuss the present and future of open science in Canada. The panel will highlight two national consortiums aimed at transforming research culture: The Canadian Reproducibility Network (CaRN) and their metascience study mapping research reproducibility in Canada, and the Tanenbaum Open Science Institute (TOSI)’s alliance of Canadian research institutions committed to open science, and their approach to measuring progress including an automated open science dashboard. A research funder’s perspective will be provided through findings from a metaresearch study on the implementation of the federal Tri-Agencies’ data management policy. Additionally, we will explore the intersection of intellectual property and open science in academia-industry partnerships, enabling the rise of an open drug discovery ecosystem in Canada. Through this cross-sectional discussion, we will address key challenges and opportunities in positioning Canada amongst global leaders in open science innovation, while also connecting our discussion to the broader international open science landscape.